Drugs / Wharton's jelly derived mesenchymal stem cell
Wharton's jelly derived mesenchymal stem cell
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04224207 Comparator | Apr → Oct 2019 | retinitis pigmentosa | Ankara University Technopolis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wharton's jelly derived mesenchymal stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04224207 ↗ |
| Modality | Cell therapy | “umbilical cord Wharton's jelly derived mesenchymal stem cells” NCT04224207 ↗ |
| Route | Other | “implanted in sub-tenon space” NCT04224207 ↗ |